People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Saluda Medical, Inc. | — | Healthtech | Series D+ | $180.0M | $232.4M | 2023 |
| CHF Solutions, Inc. | — | Biotechnology | Series A | $33.0M | $17.1M | 2012 |
Geoffrey Brooke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Geoffrey Brooke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Buckman | 1 | 10 |
| Juan-Pablo Mas | 1 | 5 |
| David A. Rosa | 1 | 5 |
| John L. Erb | 1 | 5 |
| Andrew Cleeland | 1 | 5 |
| David Rosa | 1 | 5 |
| Jon Salveson | 1 | 5 |
| JEFFREY S. MATHIESEN | 1 | 4 |
| Gregory D. Waller | 1 | 4 |
| John Erb | 1 | 3 |
| Doug Godshall | 1 | 3 |
| William Peters | 1 | 3 |
| Paul A Buckman | 1 | 3 |
| Warren Watson | 1 | 3 |
| Robert Palmisano | 1 | 3 |
| Mark Harvey | 1 | 3 |
| Warren S. Watson | 1 | 2 |
| Paul R. Buckman | 1 | 2 |
| Paul L. Buckman | 1 | 2 |
| Jeffrey Mathiesen | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.